Refine
Year of publication
Language
- English (87)
Is part of the Bibliography
- yes (87)
Keywords
- gamma rays: general (22)
- radiation mechanisms: non-thermal (21)
- gamma rays: galaxies (13)
- ISM: supernova remnants (12)
- galaxies: active (12)
- cosmic rays (10)
- acceleration of particles (9)
- astroparticle physics (7)
- gamma rays: stars (6)
- galaxies: jets (5)
Translational diffusion of the macromolecules, intrinsic viscosity and flow birefringence induced in dilute solutions of poly(1,3-phenylene-1,3,4-oxadiazole) (PMOD) in conc. sulphuric acid has been investigated. Molecular-weight dependences of hydrodynamic and dynamo-optical properties are established over the M range from 8.1 103 to 87 103. Experimental data agree well with the theories developed for translational friction and intrinsic viscosity of the wormlike chains with the following molecular parameters: mass per chain unit ML = 22.7 Dalton/Å, the Kuhn segment length A = 59 ± 4 Å, the chain diameter d = 4 ± 1.5 Å. Hindrance to intramolecular rotation is characterized by the parameter s = 1.7. The shear optical coefficient was found to be approximately 1.7 times lower the value of that obtained in the same solvent for the para-phenylene isomer of this polymer, being in good agreement with higher equilibrium flexibility of the PMOD molecule chains in solutions as determined herein from the hydrodynamic data.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m(2)/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m(2) at follow-up among those with eGFRcrea 60 mL/min/1.73m(2) or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or (LARP4B). Individuals at high compared to those at low genetic risk (8-14 vs. 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
As WR 6 is a putatively single WN4 star, and is relatively bright (V = 6.9), it is an ideal case for studying the wind mechanisms in these extremely luminous stars. To obtain higher resolution spectra at higher energy (above 1 keV) than previously obtained with the XMM/Newton RGS, we have observed WR 6 with the Chandra High Energy Transmission Grating Spectrometer for 450 ks. We have resolved emission lines of S, Si, Mg, Ne, and Fe, which all show a “fin"-shaped prole, characteristic of a self-absorbed uniformly expanding shell. Steep blue edges gives robust maximal expansion velocities of about 2000 km/s, somewhat larger than the 1700km/s derived from UV lines. The He-like lines all indicate that X-ray emitting plasmas are far from the photosphere – even at the higher energies where opacity is lowest { as was also the case for the longer wavelength lines observed with XMM-Newton/RGS. Abundances determined from X-ray spectral modeling indicate enhancements consistent with nucleosynthesis. The star was also variable in X-rays and in simultaneous optical photometry obtained with Chandra aspect camera, but not coherently with the optically known period of 3.765 days.